DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Suraksha Diagnostic Limited — Board Meeting Intimation

NSE 56 min ago·5 Nov 2026, 9:51 am

Suraksha Diagnostic

Suraksha Diagnostic Limited has announced that its board will meet on November 10, 2026, to review and approve the company's unaudited financial results for the quarter ended September 2026. This is a standard corporate procedure where the board evaluates the firm's performance before the results are made public.

For investors, this announcement is a key update. It signals that the company is preparing to disclose its latest financial health, including revenue, profit, and operational metrics. Monitoring this release is important as it provides fresh data to assess the company's current growth trajectory and operational efficiency.

Investors should watch for the specific numbers released during this board meeting. Any significant deviation from market expectations or guidance regarding future performance can lead to immediate changes in the stock's valuation. Keeping an eye on the official filing will provide clarity on the company's standing.